David Roofeh

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 10 papers. Top paper: “Tocilizumab Prevents Progression of Early Systemic Sclerosis–Associated Interstitial Lung Disease”.

Tocilizumab Prevents Progression of Early Systemic Sclerosis–Associated Interstitial Lung Disease

Arthritis & Rheumatology(2021)10.1002/art.41668

N/A

5.5DataRank · unranked

194 citations

Celia J. F. Lin, Jonathan Goldin, Grace Hyun J. Kim, Daniel E. Furst, Christopher P. Denton +4 more

Clinical characteristics, visceral involvement, and mortality in at-risk or early diffuse systemic sclerosis: a longitudinal analysis of an observational prospective multicenter US cohort

Arthritis Research & Therapy(2021)10.1186/s13075-021-02548-1

N/A

0.637DataRank · unranked

69 citations

Alain Lescoat, Suiyuan Huang, Jessica Gordon, Monique Hinchcliff, Ami A. Shah +15 more

Hospitalisations related to systemic sclerosis and the impact of interstitial lung disease. Analysis of patients hospitalised at the University of Michigan, USA

Clinical and Experimental Rheumatology(2021)10.55563/clinexprheumatol/9ivp9g

N/A

0.442DataRank · unranked

18 citations

Mirette Habib, Sara Jaafar, Vivek Nagaraja, David Roofeh, Amber Young +3 more

Domains and outcome measures for the assessment of limited cutaneous systemic sclerosis: an international collaborative scoping review

Lara D. Veeken(2022)10.1093/rheumatology/keac049

N/A

0.312DataRank · unranked

7 citations

Robert D Sandler, François Zimmermann, David Roofeh, Michael Hughes, John D Pauling +6 more

Systemic sclerosis associated interstitial lung disease: a conceptual framework for subclinical, clinical and progressive disease

Lara D. Veeken(2022)10.1093/rheumatology/keac557

N/A

0DataRank · unranked

17 citations

Kevin M. Brown, Ella A. Kazerooni, Donald P Tashkin, Shervin Assassi, Fernando J. Martínez +48 more

Undifferentiated connective tissue disease with an incidental photo-provocation: a case report

Frontiers in Lupus(2023)10.3389/flupu.2023.1223001

N/A

0DataRank · unranked

1 citations

J. Michelle Kahlenberg, David Roofeh

A pilot trial of integrating the Patient-Reported Outcome Measurement Information System (PROMIS®) into rheumatology care

Clinical and Experimental Rheumatology(2024)10.55563/clinexprheumatol/fp914f

N/A

0DataRank · unranked

0 citations

Danielle N. Ochocki, Neda Kortam, Suiyuan Huang, Vivek Nagaraja, Katherine Chakrabarti +8 more

Systemic Sclerosis–Associated Interstitial Lung Disease: How to Incorporate Two Food and Drug Administration–Approved Therapies in Clinical Practice

Arthritis & Rheumatology(2021)10.1002/art.41933

N/A

0DataRank · unranked

123 citations

Alain Lescoat, David Roofeh, Elana J. Bernstein, Ella A. Kazerooni, Michael D. Roth +4 more

Outcome measurement instrument selection for lung physiology in systemic sclerosis associated interstitial lung disease: A systematic review using the OMERACT filter 2.1 process

Seminars in Arthritis and Rheumatism(2021)10.1016/j.semarthrit.2021.08.001

N/A

0DataRank · unranked

9 citations

Shaney Barratt, Athol U. Wells, Letícia Kawano-Dourado, Donald P Tashkin, Vibeke Strand +17 more

Risk factors for lung function decline in systemic sclerosis-associated interstitial lung disease in a large single-centre cohort

Lara D. Veeken(2022)10.1093/rheumatology/keac639

N/A

0DataRank · unranked

29 citations

Alain Lescoat, David Roofeh, Vivek Nagaraja, Rajaie Namas, Suiyuan Huang +7 more